Table 1.

Description of patients with RCC metastasis to the thyroid gland from WFBMC.

Clinical characteristics of WFBMC cohort
Patient	Age (at RCC diagnosis)	Gender	Time from RCC diagnosis to thyroid metastasis, mo	Sites of metastasis	OS (from RCC diagnosis—mo)	Treatment	Status
1	61	M	45	Thyroid, lung	56	Thyroidectomy	Alive
2	50	M	17	Thyroid, brain	38	No thyroid treatment, radiation (brain), sorafenib, sunitinib, temsirolimus	Deceased
3	57	F	2	Thyroid, lung, pelvis	7	Radiation to thyroid, radiation to pelvis, temsirolimus, sunitinib	Deceased
4	58	M	99	Thyroid, lung, adrenal	126	Thyroidectomy, sunitinib, pazopanib, temsirolimus	Alive
5	53	M	17	Thyroid, pituitary, colon, lung, cavernous sinus	42	Thyroidectomy, radiation (clivus), pazopanib	Alive
6	49	M	54	Thyroid	69	Thyroidectomy, radiation (right flank)	Alive
7	39	F	173	Thyroid, adrenal	195	Thyroidectomy	Alive

Abbreviations: WFBMC, Wake Forest Baptist Medical Center; OS, overall survival; RCC, renal cell carcinoma.

First metastasis bolded if known.